Delivery Order SPE2DB22D6029-SPE2DB25FLVHD
- Not listed
- The Defense Logistics Agency Troop Support Medical awarded a $545.56 firm fixed price delivery order to Amerisourcebergen Drug Corp for 150 units of Hylenex recombinant hyaluronidase human injection. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested product from its facility in Conshohocken, Pennsylvania by August 30, 2023 in support of DLA Troop Support Medical requirements. The delivery order was issued against an existing DLA Troop Support Medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $1,884.81, is for the delivery of HYLENEX 150 UNITS/ML VIALML, a type of pharmaceutical product. The contract is a firm fixed-price Delivery Order with a period of performance ending in July 2024. There is no set-aside designation for this award. As a large pharmaceutical distributor, Amerisourcebergen has been...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,129.82 firm-fixed-price delivery order is for the supply of 4565307009 - HYLENEX 150 UNITS/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded multiple federal contracts and...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HYLENEX 150 UNITS/ML VIAL medical products. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a Ceiling Value of $1,027.30 with an Ultimate Completion Date of July 10, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $15,183.04 to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Hyqvia 30 GM-2,400 unit pack 315ML pharmaceutical products. The contract utilizes firm fixed price pricing with no set-aside designation and is expected to be completed by December 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents...
- The Defense Logistics Agency awarded a $3,213 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Heparin Sodium 5,000 Unit/0.5 ML injectable medication, with completion scheduled for October 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $3,023.55 delivery order to AmerisourceBergen Drug Corp for Heparin 25,000 unit/250-1/2 normal saline 250ml pharmaceutical product. This competitively awarded, firm fixed-price delivery order was issued on October 31, 2025, with an ultimate completion date of November 3, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $11,465.21 to AmerisourceBergen Drug Corp for Hetastarch Sodium, a plasma volume expander pharmaceutical product. This competitive, firm fixed-price delivery order, issued on December 10, 2025, with completion targeted for January 8, 2026, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,457.94 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Heparin 25,000 Unit/250-1/2 Normal Saline 250mL on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $4,324.59 to AmerisourceBergen Drug Corp for the supply of Heparin 25,000 unit/250 ml in D5W solution (250 ml units). This firm fixed-price delivery order, awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation,...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVHDDelivery Order
The Defense Logistics Agency awarded a $1,429.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for 150 units/mL of Hylenex on June 16, 2025, with completion scheduled for June 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Hylenex is a recombinant human enzyme used to facilitate the subcutaneous administration of fluids and medications. AmerisourceBergen, as a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order exemplifies the company's role as a primary pharmaceutical supplier through the DLA Troop Support Medical contract vehicle, which enables the company to deliver specialized medications and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/16/25 |